These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
914 related articles for article (PubMed ID: 28970292)
1. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia. Singhi AD; McGrath K; Brand RE; Khalid A; Zeh HJ; Chennat JS; Fasanella KE; Papachristou GI; Slivka A; Bartlett DL; Dasyam AK; Hogg M; Lee KK; Marsh JW; Monaco SE; Ohori NP; Pingpank JF; Tsung A; Zureikat AH; Wald AI; Nikiforova MN Gut; 2018 Dec; 67(12):2131-2141. PubMed ID: 28970292 [TBL] [Abstract][Full Text] [Related]
2. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts. Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521 [TBL] [Abstract][Full Text] [Related]
3. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts. Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016 [TBL] [Abstract][Full Text] [Related]
4. KRAS/GNAS-testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound-guided workup of suspected mucinous neoplasms of the pancreas. Schmitz D; Kazdal D; Allgäuer M; Trunk M; Vornhusen S; Nahm AM; Doll M; Weingärtner S; Endris V; Penzel R; Kirchner M; Brandt R; Neumann O; Sültmann H; Budczies J; Kienle P; Magdeburg R; Hetjens S; Schirmacher P; Bergmann F; Rudi J; Stenzinger A; Volckmar AL Genes Chromosomes Cancer; 2021 Jul; 60(7):489-497. PubMed ID: 33686791 [TBL] [Abstract][Full Text] [Related]
5. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data. Singhi AD; Zeh HJ; Brand RE; Nikiforova MN; Chennat JS; Fasanella KE; Khalid A; Papachristou GI; Slivka A; Hogg M; Lee KK; Tsung A; Zureikat AH; McGrath K Gastrointest Endosc; 2016 Jun; 83(6):1107-1117.e2. PubMed ID: 26709110 [TBL] [Abstract][Full Text] [Related]
6. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms. Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845 [TBL] [Abstract][Full Text] [Related]
7. Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA. Faias S; Duarte M; Albuquerque C; da Silva JP; Fonseca R; Roque R; Dias Pereira A; Chaves P; Cravo M Dig Dis Sci; 2018 Sep; 63(9):2351-2361. PubMed ID: 29796909 [TBL] [Abstract][Full Text] [Related]
8. Mutational Mosaics of Cell-Free DNA from Pancreatic Cyst Fluids. Paziewska A; Polkowski M; Goryca K; Karczmarski J; Wiechowska-Kozlowska A; Dabrowska M; Mikula M; Ostrowski J Dig Dis Sci; 2020 Aug; 65(8):2294-2301. PubMed ID: 31925676 [TBL] [Abstract][Full Text] [Related]
9. Next generation sequencing of the cellular and liquid fraction of pancreatic cyst fluid supports discrimination of IPMN from pseudocysts and reveals cases with multiple mutated driver clones: First findings from the prospective ZYSTEUS biomarker study. Volckmar AL; Endris V; Gaida MM; Leichsenring J; Stögbauer F; Allgäuer M; von Winterfeld M; Penzel R; Kirchner M; Brandt R; Neumann O; Sültmann H; Schirmacher P; Rudi J; Schmitz D; Stenzinger A Genes Chromosomes Cancer; 2019 Jan; 58(1):3-11. PubMed ID: 30230086 [TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of EUS-acquired pancreatic cyst fluid for KRAS and GNAS mutations for diagnosis of intraductal papillary mucinous neoplasia and mucinous cystic lesions: a systematic review and meta-analysis. McCarty TR; Paleti S; Rustagi T Gastrointest Endosc; 2021 May; 93(5):1019-1033.e5. PubMed ID: 33359054 [TBL] [Abstract][Full Text] [Related]
12. Next-generation sequencing adds value to the preoperative diagnosis of pancreatic cysts. Rosenbaum MW; Jones M; Dudley JC; Le LP; Iafrate AJ; Pitman MB Cancer Cytopathol; 2017 Jan; 125(1):41-47. PubMed ID: 27647802 [TBL] [Abstract][Full Text] [Related]
14. Activation of the RAS pathway through uncommon BRAF mutations in mucinous pancreatic cysts without KRAS mutation. Ren R; Krishna SG; Chen W; Frankel WL; Shen R; Zhao W; Avenarius MR; Garee J; Caruthers S; Jones D Mod Pathol; 2021 Feb; 34(2):438-444. PubMed ID: 32792597 [TBL] [Abstract][Full Text] [Related]
15. GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs". Matthaei H; Wu J; Dal Molin M; Shi C; Perner S; Kristiansen G; Lingohr P; Kalff JC; Wolfgang CL; Kinzler KW; Vogelstein B; Maitra A; Hruban RH Am J Surg Pathol; 2014 Mar; 38(3):360-3. PubMed ID: 24525507 [TBL] [Abstract][Full Text] [Related]
16. Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts. Nikiforova MN; Khalid A; Fasanella KE; McGrath KM; Brand RE; Chennat JS; Slivka A; Zeh HJ; Zureikat AH; Krasinskas AM; Ohori NP; Schoedel KE; Navina S; Mantha GS; Pai RK; Singhi AD Mod Pathol; 2013 Nov; 26(11):1478-87. PubMed ID: 23743931 [TBL] [Abstract][Full Text] [Related]
17. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Kanda M; Knight S; Topazian M; Syngal S; Farrell J; Lee J; Kamel I; Lennon AM; Borges M; Young A; Fujiwara S; Seike J; Eshleman J; Hruban RH; Canto MI; Goggins M Gut; 2013 Jul; 62(7):1024-33. PubMed ID: 22859495 [TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing of residual cytologic fixative preserved DNA from pancreatic lesions: A pilot study. Fulmer CG; Park K; Dilcher T; Ho M; Mirabelli S; Alperstein S; Hissong EM; Pittman M; Siddiqui M; Heymann JJ; Yantiss RK; Borczuk AC; Fernandes H; Sigel C; Song W; Mosquera JM; Rao R Cancer Cytopathol; 2020 Nov; 128(11):840-851. PubMed ID: 32598087 [TBL] [Abstract][Full Text] [Related]
19. Activating mutations of GNAS and KRAS in cystic fluid can help detect intraductal papillary mucinous neoplasms of the pancreas. Frampton AE; Stebbing J; Gall TM; Silver B; Jiao LR; Krell J Expert Rev Mol Diagn; 2015 Mar; 15(3):325-8. PubMed ID: 25656048 [TBL] [Abstract][Full Text] [Related]
20. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. Amato E; Molin MD; Mafficini A; Yu J; Malleo G; Rusev B; Fassan M; Antonello D; Sadakari Y; Castelli P; Zamboni G; Maitra A; Salvia R; Hruban RH; Bassi C; Capelli P; Lawlor RT; Goggins M; Scarpa A J Pathol; 2014 Jul; 233(3):217-27. PubMed ID: 24604757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]